Next Article in Journal
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Next Article in Special Issue
Prostate-Derived ETS Factor (PDEF) Modulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling
Previous Article in Journal
Synthesis and Study of New Quinolineaminoethanols as Anti-Bacterial Drugs
Previous Article in Special Issue
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression

CDK8-Novel Therapeutic Opportunities

Institute of Pharmacology and Toxicology, University of Veterinary Medicine, 1210 Vienna, Austria
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 92;
Received: 10 May 2019 / Revised: 11 June 2019 / Accepted: 17 June 2019 / Published: 19 June 2019
(This article belongs to the Collection Protein Kinases and Cancer)
Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target for breast and prostate cancer, although no CDK8 inhibitors have entered the clinics. As the available inhibitors have been recently reviewed, we focus on the biological functions of CDK8 and provide an overview of the complexity of CDK8-dependent signaling throughout evolution and CDK8-dependent effects that may open novel treatment avenues. View Full-Text
Keywords: CDK8; mediator complex; cancer CDK8; mediator complex; cancer
Show Figures

Figure 1

MDPI and ACS Style

Menzl, I.; Witalisz-Siepracka, A.; Sexl, V. CDK8-Novel Therapeutic Opportunities. Pharmaceuticals 2019, 12, 92.

AMA Style

Menzl I, Witalisz-Siepracka A, Sexl V. CDK8-Novel Therapeutic Opportunities. Pharmaceuticals. 2019; 12(2):92.

Chicago/Turabian Style

Menzl, Ingeborg, Agnieszka Witalisz-Siepracka, and Veronika Sexl. 2019. "CDK8-Novel Therapeutic Opportunities" Pharmaceuticals 12, no. 2: 92.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop